BioIntelliSense: Funding, Investors & Team (Oct 2026)
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM) and Health Screening. Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The FDA-cleared BioSticker™ and BioButton® devices make remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians will now have access to high-resolution patient trending and reporting to enable medical grade care from in the hospital to the home, and all points in-between.
BioIntelliSense has raised $45.0M across 1 funding round on record, the most recent a Series B of $45.0M announced in Jul 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioIntelliSense Company Profile and Key Stats
Latest funding round on record: Jul 2021.
BioIntelliSense Funding Rounds
BioIntelliSense Founders and Leadership Team
Contact details for the BioIntelliSense team: 1 of 1 has an email address on file.
Start 14-day free trial →BioIntelliSense Funding Compared to Other Biotechnology Startups
BioIntelliSense's latest round of $45.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioIntelliSense in Biotechnology and Golden
Companies Similar to BioIntelliSense
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BioIntelliSense Funding FAQs
What does BioIntelliSense do?
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM) and Health Screening. Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The FDA-cleared BioSticker™ and BioButton® devices make remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians will now have access to high-resolution patient trending and reporting to enable medical grade care from in the hospital to the home, and all points in-between.
How much funding has BioIntelliSense raised?
BioIntelliSense has raised $45.0M across 1 round on record. The most recent is a Series B of $45.0M announced in Jul 2021.
When did BioIntelliSense last raise funding?
BioIntelliSense's most recent funding round on record is a Series B of $45.0M, announced in Jul 2021.
Who is the CEO of BioIntelliSense?
James Mault is listed as CEO at BioIntelliSense.
Where is BioIntelliSense headquartered?
BioIntelliSense is based in Golden, Colorado, United States.
How many employees does BioIntelliSense have?
BioIntelliSense is in the 51-100 employee band.
How does BioIntelliSense's funding compare to other Biotechnology startups?
BioIntelliSense's latest round of $45.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BioIntelliSense Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioIntelliSense is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.